Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...

In nulliparous pregnant individuals, higher radon exposure is associated with greater odds of gestational diabetes (GD).

In line with trial results, real-world data suggest GLP-1 receptor agonists have certain benefits in patients with moderate to severe chronic kidney disease (CKD).

Academic detailing interventions significantly improved more than half of evidence-based prescribing outcomes.

A study has found that convenient access to a nearby major park in young adulthood may improve cardiovascular health in midlife.

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Hallmark symptoms of Cushing disease, including abdominal striae and facial rounding, were more common among younger patients than older patients.

There are racial and sex disparities in the discussion of and progression to metabolic and bariatric surgery (MBS) among eligible patients.

In the first 22 months of a mavacamten REMS program, few patients needed a temporary interruption in treatment for LVEF below 50%.

Linzagolix with and without concomitant add-back therapy was associated with reductions in heavy menstrual bleeding in uterine fibroids.

Adiponectin levels were associated with increased likelihood of metabolic health improvements and lower risk for diabetes across 6 years.